Pure Global

READY-TO-USE SYRINGE CONTAINING PROLIA 60 MG/ML SC SOLUTION FOR INJECTION, 1 PIECE - Turkey License ca40dff67bfca45a35979d92cd42bef5

Access comprehensive regulatory information for READY-TO-USE SYRINGE CONTAINING PROLIA 60 MG/ML SC SOLUTION FOR INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number ca40dff67bfca45a35979d92cd42bef5 with license number 2022/446and contains active ingredient Denosumab. The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
ca40dff67bfca45a35979d92cd42bef5
License Details
Turkey SFDA License: ca40dff67bfca45a35979d92cd42bef5
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

READY-TO-USE SYRINGE CONTAINING PROLIA 60 MG/ML SC SOLUTION FOR INJECTION, 1 PIECE
TR: PROLİA 60 MG/ML SC ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET
Pharmaceutical Product

License Details

ca40dff67bfca45a35979d92cd42bef5

2022/446

8699862950251

M05BX04

License Holder Information

Active Ingredient

Denosumab

License Information

Aug 12, 2022